Preferred Label : oxymetazoline;

MeSH definition : A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251);

MeSH hyponym : oxymetazoline hydrochloride; Hydrochloride, Oxymetazoline;

MeSH CAS label : phenol, 3-((4,5-dihydro-1H-imidazol-2-yl)methyl)-6-(1,1-dimethylethyl)-2,4-dimethyl-;

MeSH Related Number : 1491-59-4 (Oxymetazoline); oxymetazoline hydrochloride; K89MJ0S5VY;

Registry Number MeSH : 1491-59-4;

Related CAS MeSH : K89MJ0S5VY (Oxymetazoline hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Oxymetazoline hydrochloride;

Codes EINECS : 216-079-1;

Is substance : O;

UNII : 8VLN5B44ZY;

InChIKey : WYWIFABBXFUGLM-UHFFFAOYSA-N;

Details


Main resources

You can consult :

A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)

http://www.has-sante.fr/jcms/c_2561319/fr/pernazene
http://www.has-sante.fr/jcms/c_1121563/pernazene
2015
false
France
French
evaluation of the transparency committee
sinusitis
Nasal Congestion
oxymetazoline hydrochloride
administration, intranasal
insurance, health, reimbursement
treatment outcome
oxymetazoline
nasal decongestants
adrenergic alpha-agonists
sympathomimetics
oxymetazoline
rhinitis
acute disease
adult
adolescent
nasal sprays

---
http://www.has-sante.fr/jcms/c_1121577/aturgyl
http://www.has-sante.fr/upload/docs/application/pdf/2011-11/aturgyl_05-10-2011_avis_ct-11266.pdf
2011
France
French
oxymetazoline
oxymetazoline
administration, intranasal
administration, intranasal
nasal sprays
nasal sprays
oxymetazoline
oxymetazoline
nasal decongestants
nasal decongestants
insurance, health, reimbursement
insurance, health, reimbursement
treatment outcome
treatment outcome
adult
adult
adolescent
adolescent
rhinitis
rhinitis
sinusitis
sinusitis
sympathomimetics
sympathomimetics
adrenergic alpha-agonists
adrenergic alpha-agonists
evaluation of the transparency committee
evaluation of the transparency committee
Rhinosinusitis
Rhinosinusitis

---
http://www.has-sante.fr/jcms/c_1121581/deturgylone
http://www.has-sante.fr/upload/docs/application/pdf/2011-11/deturgylone_05-10-2011_avis_ct-11269.pdf
http://www.has-sante.fr/jcms/c_468405/deturgylone
2011
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
drug combinations
nasal sprays
administration, intranasal
oxymetazoline
prednisolone phosphate
prednisolone
prednisolone, combinations
glucocorticoids
nasal decongestants
anti-inflammatory agents
rhinitis
acute disease
adult
treatment outcome
insurance, health, reimbursement
adolescent
adrenergic alpha-agonists
sympathomimetics
evaluation of the transparency committee

---
http://www.has-sante.fr/display.jsp?id=c_468482
http://www.has-sante.fr/upload/docs/application/pdf/ct-3154_aturgyl_.pdf
2006
France
French
nasal decongestants
nasal decongestants
oxymetazoline
oxymetazoline
administration, intranasal
administration, intranasal
oxymetazoline
oxymetazoline
insurance, health, reimbursement
insurance, health, reimbursement
adult
adult
nasal sprays
nasal sprays
evaluation of the transparency committee
evaluation of the transparency committee

---
Nous contacter.
01/02/2026


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.